Cue Biopharma (CUE) Capital Expenditures Growth (1y) (2018 - 2025)
Cue Biopharma (CUE) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
170.00% |
| Mar 31, 2025 |
172.73% |
| Dec 31, 2022 |
2,464.10% |
| Sep 30, 2022 |
500.00% |
| Jun 30, 2022 |
-74.21% |
| Mar 31, 2022 |
-95.83% |
| Dec 31, 2021 |
-99.96% |
| Sep 30, 2021 |
-96.24% |
| Jun 30, 2021 |
100.18% |
| Mar 31, 2021 |
-99.54% |
| Dec 31, 2020 |
945.68% |
| Sep 30, 2020 |
1,935.29% |
| Mar 31, 2020 |
740,136.84% |
| Dec 31, 2019 |
-91.39% |
| Sep 30, 2019 |
-94.35% |
| Mar 31, 2019 |
-97.18% |
| Dec 31, 2018 |
112.74% |
| Sep 30, 2018 |
44.71% |
| Jun 30, 2018 |
-1.81% |
| Mar 31, 2018 |
2,220.69% |
